In today's episode, we'll cover an AI-developed drug entering phase 2 clinical trials, concerns of European tech firms and VCs over-regulation of AI, UK regulator scrutinizing Adobe's Figma acquisition, Facebook potentially enabling EU users to download apps directly from ads, Twitter's new login requirement and its impact on user growth and search engine rankings and YouTube's testing of blocking ad-blocker users